Table 2

Significant loci associating with the circulating inflammatory phenotypes

StudyMarkerLocusChr:PositionCandidate geneNearest gene(s)AnnotationdbSNP referenceINFOEAEAFBetaP valueHetPValVariance explainedTotal variance explained
NFBC1966sE-selectin9q34.29:136 141 870 ABO ABO Intronicrs25190930.994T0.188−0.9034.48e-305NA0.2490.258
11q24.2 11:126 266 665 ST3GAL4 ST3GAL4 Intronic rs11220471 0.967 G 0.212 0.162 7.72e-12 NA 0.009
sICAM-19q34.29:136 141 870 ABO ABO Intronicrs25190930.994T0.188−0.3527.43e-48NA0.0380.118
19p13.219:10 383 403 ICAM1 ICAM1 Intronicrs1179607960.802A0.012−1.6698.03e-40NA0.066
19p13.219:10 497 360 ICAM1 CDC37 Intergenicrs744286140.992A0.1630.2261.14e-16*NA0.014
sVCAM-1 9q34.2 9:136 131 322 ABO ABO Missense rs8176746 1.000 T 0.129 0.256 5.06e-19 NA 0.015 0.038
12q23.3 12:104 448 391 HSP90B1 GLT8D2 Intronic rs117238625 0.981 A 0.023 0.510 2.90e-14 NA 0.012
17q24.2 17:66 823 805 ABCA8 ABCA8 Intergenic rs112001035 0.883 A 0.060 0.324 1.04e-13 NA 0.012
Meta-analysesIL1β 6p22.1 6:30 017 071 HLA locus Intronic rs6917603 1.000 C 0.251 0.163 1.76e-12 1.00 0.010 0.015
6p22.1 6:30 013 887 HLA locus Intronic rs9261224 1.000 T 0.035 0.261 1.31e-09 * 1.00 0.005
IP104q21.14:76 899 176 CXCL10 SAD1 Intronicrs1927163150.851C0.0031.5132.71e-131.000.0140.014
MCP11q23.21:159 175 354 ACKR1 ACKR1 Missensers120751.000A0.4690.1481.43e-331.51e-130.0110.011
TNFα 13q14.3 13:51 141 997 DLEU1 DLEU1 Intronic rs17074575 0.803 G 0.002 2.131 2.71e-09 1.00 0.018 0.018
VEGF 4p16.2 4:5 636 073 STK32B EVC2 Intronic rs186725382 0.875 A 0.001 2.380 4.53e-10 1.00 0.011 0.052
6p21.16:43 927 050 VEGFA C6orf223 Intergenicrs77673961.000A0.5230.2848.35e-1051.22e-690.0400.056
9p24.29:2 686 273 VLDLR VLDLR, KCNV2 Intergenicrs70307810.959T0.373-0.0991.57e-135.34e-040.005
  • Statistical significance is considered at p<3.1×10−9. Novel findings are highlighted with bold font. All positions correspond to human genome build 37.

  • *Indicates associations that are significant after conditioning the analyses on the locus-specific lead variant on the preceding row.

  • EA, effect allele; EAF, effect allele frequency; HLA, human leukocyte antigen; HetPVal, p value of heterogeneity as estimated by Cochrane’s Q-test; IL1β, interleukin 1-beta ; INFO, imputation score in NFBC1966; IP10, interferon gamma-induced protein 10; MCP1, monocyte chemoattractant protein 1; NA, not available; NA, not available; NFBC1966, Northern Finland Birth Cohort 1966; TNFα, tumour necrosis factor alpha; VEGF, vascular endothelial growth factor; dbSNP, single nucleotide polymorphism database; sE-selectin, soluble E-selectin; sICAM-1, soluble intercellular adhesion molecule -1; sVCAM-1, soluble vascular cell adhesion molecule-1.